Abstract:BACKGROUND: Growth-associated protein-43 is the primary substance for constructing plasticity of central nervous system, which is recognized as the first molecular marker for studying growth and repairing injury of nerves. OBJECTIVE: To explore the expression of growth-associated protein-43 in rats with focal cerebral ischemia following bone marrow mesenchymal stem cells (MSCs) transplantation. DEISNG, TIME AND SETTING: A randomized, controlled, animal study was performed at the Laboratory of Department of Neurology, Renmin Hospital of Wuhan University and Doctoral Scientific Research Work Station of C-BONS Pharmacy, Hubei, China, from March 2006 to October 2007. MATERIALS: Sixty adult Sprague Dawley rats, with clean grade, irrespective of genders, weighing (180±20) g, were randomly divided into the model, sham operated, and MSCs transplantation groups, with 20 animals in each group. METHODS: Additional 4 Sprague Dawley rats, aged 2 months, were selected to isolate and culture MSCs, which was labeled with 5-Bromo-2, -deoxyuridine (BrdU). In the sham operated group, the right internal carotids were deligated after anaesthesia. The remained rats were prepared for models of right middle cerebral artery ischemia. At 24 hours after model preparation, 20 μL culture solution containing 5×10^5 /L MSCs was injected into the left lateral ventricle of rats in the MSCs group, the same volume of phosphate buffer saline was injected in the model group. MAIN OUTCOME MEASURES: The rats were sacrificed prior to and at days 7, 14, and 21 after transplantation. The expression of growth associated protein-43 at the infarcted areas, the survival and migration of transplanted cells were examined by immunohistochemistry, at the same time, neurological deficit scores were recorded. RESULTS: The transplanted MSCs migrated from the left lateral ventricle to the infracted areas. Seven days after transplantation, the expression of BrdU-positive cells was found, reached a peak at day 14, and gradually decreased, until disappeared at 28 days after transplantation. Results of immunohistochemistry image analysis showed that immunological activity of growth associated protein-43 around the infarcted area of the MSCs group was obviously greater than that of the model group at days 7 and 14 after transplantation (P＜0.05). There was no neurological deficit in the sham operated group. Moreover, with time prolonged, the neurological deficit scores gradually decreased in the model and MSCs groups, which were significantly lower in the MSCs group compared to the model group at day 14 after transplantation (P＜0.05). CONCLUSION: MSCs transplantation up-regulates the expression of growth associated protein-43 around the infarcted area, which is consistent with the recovery of neurological function.

Neuroprotective effects of bone marrow stem cells overexpressing glial cell line-derived neurotrophic factor on rats with intracerebral hemorrhage and neurons exposed to hypoxia/reoxygenation.

Neuroprotetive effect of glial cell line-derived neurotrophic factor gene-modified bone marrow stromal cells transplantation on intracerebral hemorrhage in rats

Transplantation of Hypoxia Preconditioned Bone Marrow Mesenchymal Stem Cells Enhances Angiogenesis and Neurogenesis after Cerebral Ischemia in Rats.

Neuroprotective Effect Of Grafting Gdnf Gene-Modified Neural Stem Cells On Cerebral Ischemia In Rats

Effect of Bone Marrow Stromal Cell Transplantation on Neurologic Function and Expression of VEGF in Rats with Focal Cerebral Ischemia

Intraparenchymal treatment with bone marrow mesenchymal stem cell-conditioned medium exerts neuroprotection following intracerebral hemorrhage.

Intravenous Administration of Hair Follicle Mesenchymal Stem Cells and Insulin Growth Factor-1 Improves the Neurological Performances of Rats Following Focal Cerebral Ischemia

Overexpression of vascular endothelial growth factor enhances the neuroprotective effects of bone marrow mesenchymal stem cell transplantation in ischemic stroke

Neuroprotective Effects of Intravenous Transplantation of Bone Marrow Mononuclear Cells from 5-Fluorouracil Pre-Treated Rats on Ischemic Stroke

Intranasal Delivery of Hypoxia-Preconditioned Bone Marrow-Derived Mesenchymal Stem Cells Enhanced Regenerative Effects after Intracerebral Hemorrhagic Stroke in Mice

Influence of Bone Marrow Mesenchymal Stem Cell Transplantation on Growth-Associated Protein-43 Expression in Rats with Cerebral Infarction

[Treatment of Stroke in Rats with Bone Marrow Mesenchymal Stem Cells].

Effects of Human Bone Marrow Stromal Cells Intracerebral Transplantation on the Improvement of Hypoxic-Ischemic Brain Damage in Rats

Upregulated Gene Expression of Local Brain-Derived Neurotrophic Factor and Nerve Growth Factor after Intracisternal Administration of Marrow Stromal Cells in Rats with Traumatic Brain Injury

Enhanced Neuroprotective Efficacy of Bone Marrow Mesenchymal Stem Cells Co-Overexpressing BDNF and VEGF in a Rat Model of Cardiac Arrest-Induced Global Cerebral Ischemia

Anti-inflammatory and antiapoptotic effects of mesenchymal stem cells transplantation in rat brain with cerebral ischemia.

Expression of Cytokines in Rat Brain with Focal Cerebral Ischemia after Grafting with Bone Marrow Stromal Cells and Endothelial Progenitor Cells

Survival and differentiation of basic fibroblast growth factor gene modified bone marrow mesenchymal stem cells following vein transplantation in cerebral ischemia model rats validated by double immunofluorescence staining

The Grafting Neural Stem Cells Modified by GDNF Gene Enhances the Expression of GAP-43 in Rats Subjected to Cerebral Ischemia Reperfusion

Effect of bone marrow mesenchymal stem cell transplantation in the treatment of ischemic brain injury in rats.

Transplantation of VEGF-mediated bone marrow mesenchymal stem cells promotes functional improvement in a rat acute cerebral infarction model